HETLIOZ (TASIMELTEON) CAPSULES
Live / Applied — New application — not yet assigned to an examiner (as of 29 Oct 2026)
What this means for you
Not registered yet, but its 29 Oct 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 50189635
- Mark type
- Design + words
- Filed
- 29 Oct 2026
- Attorney of record
- Jayme M. Torelli
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations in the form of capsules containing tasimelteon for the treatment of Autism Spectrum Disorder; Pharmaceutical preparations in the form of capsules containing tasimelteon for the treatment of Delayed Sleep Phase Disorder; Pharmaceutical preparations in the form of capsules containing tasimelteon for the treatment of Jet Lag Disorder; Pharmaceutical preparations in the form of capsules containing tasimelteon for the treatment of depression; Pharmaceutical preparations in the form of capsules containing tasimelteon for the treatment of Major Depressive Disorder; Pharmaceutical preparations in the form of capsules containing tasimelteon for the treatment of REM Sleep Behavior Disorder
Owner
- Vanda Pharmaceuticals Inc., Washington, DC, US
Prior registrations
Prosecution history
- 29 Oct 2026 — APPLICATION FILING RECEIPT MAILED
- 29 Oct 2026 — NEW APPLICATION ENTERED